You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

benralizumab

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retrospective Study in UK Severe Asthma Centres

Completed
  • Asthma
  • Benralizumab
  • Cambridge, United Kingdom
  • +7 more
Jun 28, 2023

COPD (COPD) Trial (Benralizumab, Benralizumab , Comparison (control) group; no intervention)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Benralizumab
  • +2 more
  • (no location specified)
Apr 26, 2022

Asthma Trial in Worldwide (Benralizumab, Placebo)

Not yet recruiting
  • Asthma
  • Benralizumab
  • Placebo
  • Owensboro, Kentucky
  • +6 more
Jan 11, 2023

Solid Tumor, Solid Carcinoma, Solid Tumor, Adult Trial in United States (Benralizumab)

Recruiting
  • Solid Tumor
  • +3 more
  • Benralizumab
  • Basking Ridge, New Jersey
  • +4 more
Jan 18, 2023

Impact of Eosinophil Depletion on T2 Inflammation. (BEUTI)

Not yet recruiting
  • Asthma
  • Benralizumab
  • London, United Kingdom
    Guy's & St Thomas' NHS Foundation Trust
Apr 26, 2023

Severe Uncontrolled Asthma Trial in Japan, United States (Benralizumab)

Completed
  • Severe Uncontrolled Asthma
  • Benralizumab
  • Los Angeles, California
  • +14 more
Oct 7, 2022

Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

Active, not recruiting
Has Results
  • Respiratory System Agents
  • +4 more
  • benralizumab
  • Placebo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022

Dermatitis, Atopic, Dermatitis, Eczema Trial in Hamilton (Benralizumab, Placebo Control)

Completed
  • Dermatitis, Atopic
  • +9 more
  • Benralizumab
  • Placebo Control
  • Hamilton, Ontario, Canada
    McMaster Cardio-Respiratory Research Lab
Oct 14, 2021

Asthma Trial in Denver (Benralizumab)

Active, not recruiting
  • Asthma
  • Benralizumab
  • Denver, Colorado
    National Jewish Health
Mar 4, 2021

Breast Cancer Trial in United States (Benralizumab, fulvestrant or AIs) and PI3K inhibition (alpelisib))

Recruiting
  • Breast Cancer
  • Benralizumab
  • fulvestrant or AIs) and PI3K inhibition (alpelisib)
  • Stanford, California
  • +8 more
Aug 1, 2023

Chronic Rhinosinusitis (Diagnosis), Nasal Polyps, Eosinophilia Trial in Baltimore (Benralizumab, Placebo)

Completed
Has Results
  • Chronic Rhinosinusitis (Diagnosis)
  • +2 more
  • Benralizumab
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Jan 20, 2021

Asthma; Eosinophilic Trial in London (Benralizumab, 129 Xenon)

Active, not recruiting
  • Asthma; Eosinophilic
  • Benralizumab
  • 129 Xenon
  • London, Ontario, Canada
    Robarts Research Insitute; The University of Western Ontario; Lo
Sep 18, 2020

Asthma Trial in Worldwide (Benralizumab, Placebo)

Completed
Has Results
  • Asthma
  • Benralizumab
  • Placebo
  • Scottsboro, Alabama
  • +53 more
Oct 15, 2019

Severe Eosinophilic Asthma Trial in Rostock (Benralizumab)

Unknown status
  • Severe Eosinophilic Asthma
  • Benralizumab
  • Rostock, Mecklenburg-Vorpommern, Germany
    University of Rostock
Aug 27, 2018

Asthma Trial in United States (Benralizumab, Benralizumab Placebo, Seasonal influenza virus vaccine)

Completed
Has Results
  • Asthma
  • Benralizumab
  • +2 more
  • Birmingham, Alabama
  • +23 more
Oct 23, 2018

Eosinophilic Chronic Rhinosinusitis Trial in Tokyo (benralizumab, Placebo)

Completed
  • Eosinophilic Chronic Rhinosinusitis
  • benralizumab
  • Placebo
  • Tokyo, Japan
    (unnamed)
Apr 20, 2018

Asthma, Exercise-Induced Trial (Benralizumab)

Unknown status
  • Asthma, Exercise-Induced
  • Benralizumab
  • (no location specified)
Oct 26, 2017